KBC Group NV

Position in ALKS — Alkermes plc.

CIK 1411133 Brussels, C9

Position in ALKS

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$180,548

+$37,683 QoQ

Shares Held

5,106

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

KBC Group NV holds $69,833,201 across 25 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	344,903	$40,770,982
2	VTRS	Viatris Inc	1,045,698	$14,127,379
3	UTHR	UNITED THERAPEUTICS Corp	8,878	$5,264,475
4	INDV	Indivior Pharmaceuticals, Inc.	75,831	$2,311,328
5	NBIX	Neurocrine Biosciences Inc	17,011	$2,241,028
6	ELAN	Elanco Animal Health Inc	91,785	$2,196,415
7	TEVA	Teva Pharmaceutical Industries Ltd	55,414	$1,669,069
8	ALKS	Alkermes plc. This page	5,106	$180,548

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$180,548	5,106	0.0%	Shares	Defined	2026-05-07
2025-12-31	$142,865	5,106	0.0%	Shares	Defined	2026-01-26
2025-09-30	$153,180	5,106	+27.6%	Shares	Defined	2026-01-20
2025-06-30	$114,468	4,001	-44.2%	Shares	Defined	2025-08-08
2025-03-31	$236,951	7,176	0.0%	Shares	Defined	2025-04-25
2024-12-31	$206,381	7,176	+46.7%	Shares	Defined	2025-01-22
2024-09-30	$136,871	4,890	+18.8%	Shares	Defined	2024-11-06
2024-06-30	$99,195	4,116	+4.0%	Shares	Defined	2024-07-17
2024-03-31	$107,115	3,957	+25.3%	Shares	Defined	2024-05-08
2023-12-31	$87,575	3,157	0.0%	Shares	Defined	2024-02-13
2023-09-30	$88,427	3,157	+151.4%	Shares	Defined	2024-02-15
2021-03-31	$23,462	1,256	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.